Envoy Medical (COCH) Shares Outstanding (2020 - 2026)

Envoy Medical has reported Shares Outstanding (Entity) for 7 years, with the latest figure at $76.9 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 260.49% year-over-year to $76.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $76.9 million (up 260.49% YoY) and the FY2025 annual result came in at $23.3 million, up 9.06% from the prior year.
• Shares Outstanding (Entity) rose to $76.9 million in Q1 2026 per COCH's latest filing, from $23.3 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $76.9 million in Q1 2026 and troughed at $10.1 million in Q2 2023.
• A 5-year average of $28.3 million and a median of $21.5 million in 2025 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2023 and 2026: Shares Outstanding (Entity) tumbled 76.18% in 2023, then soared 260.49% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $42.5 million in 2022, then plunged by 70.46% to $12.6 million in 2023, then surged by 69.89% to $21.3 million in 2024, then climbed by 9.06% to $23.3 million in 2025, then soared by 230.53% to $76.9 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $76.9 million, $23.3 million, and $23.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.